Equities

Shanghai MicroPort MedBot Group Co Ltd

Shanghai MicroPort MedBot Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)6.81
  • Today's Change0.08 / 1.19%
  • Shares traded1.34m
  • 1 Year change-67.02%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai MicroPort MedBot Group Co Ltd is a China-based company primarily engaged in the provision of intelligent surgery total solutions. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)112.91m
  • Net income in HKD-1.09bn
  • Incorporated2015
  • Employees650.00
  • Location
    Shanghai MicroPort MedBot Group Co LtdRoom 101, Area B, Building 1601 Zhangdong Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.medbotsurgical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
China Isotope & Radiation Corp7.16bn400.49m3.42bn3.11k8.550.67553.160.47781.251.2522.3915.840.53124.221.842,306,913.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd569.75m-85.00m3.58bn765.00--1.06--6.28-0.2587-0.25871.7310.150.15920.9991480.65744,770.60-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
Yidu Tech Inc871.30m-210.46m3.64bn902.00--0.8388--4.18-0.2001-0.20010.82854.090.1658114.901.36965,962.60-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96------
Modern Dental Group Ltd3.17bn404.10m3.88bn7.04k9.661.487.091.220.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Microport NeuroTech Ltd-100.00bn-100.00bn4.56bn571.00------------------------------------------------21.61--768.73------
Shanghai Conant Optical Co Ltd1.90bn353.04m4.78bn2.51k13.533.1711.502.520.82760.82764.453.530.93282.166.48757,139.4017.3412.5722.4018.6937.4035.2718.5814.642.15--0.133518.5712.7015.5631.5633.0413.49--
Shanghai INT Medical Instruments Co Ltd812.74m168.91m4.89bn1.57k28.232.6622.576.020.98470.98474.7410.470.39042.227.75518,661.307.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
AK Medical Holdings Ltd1.18bn196.59m4.96bn1.05k25.171.9216.834.200.17560.17561.062.300.37870.84062.381,122,533.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd351.83m163.59m6.21bn219.0037.942.9834.5117.640.47180.47181.016.000.17170.584810.301,606,525.007.98--8.25--88.62--46.50--22.93--0.0013--31.58--864.81------
LifeTech Scientific Corp1.37bn284.19m6.44bn1.45k21.931.7733.874.700.06340.06340.30770.78580.30220.749110.46946,064.502.567.093.058.5178.5779.668.4822.692.27--0.14590.0015.4817.88-19.0916.8026.11--
New Horizon Health Ltd1.47bn119.43m6.47bn1.04k59.172.0141.624.400.2390.2393.227.040.45362.162.081,674,671.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
Shanghai MicroPort MedBot Group Co Ltd112.91m-1.09bn6.62bn650.00--11.64--58.59-1.14-1.140.11780.5850.06230.374642.10173,715.10-60.96---86.19--14.05---978.59--0.8238-11.040.5427--384.16--11.20------
Kangji Medical Holdings Ltd999.71m544.13m6.79bn1.00k12.051.7312.966.790.4640.4640.85253.240.22451.764.76996,720.3010.9714.4012.4516.1880.0481.7548.8457.2417.16--0.01149.5817.7621.235.2828.0041.50--
Angelalign Technology Inc1.59bn57.73m8.95bn2.88k154.642.4861.945.620.34210.34219.4421.330.31945.3316.70552,692.101.055.761.297.5962.3864.333.3013.984.12--0.0188--16.2424.75-74.99-2.2020.54--
MicroPort Scientific Corp7.42bn-3.73bn9.65bn8.23k--1.63--1.30-2.04-2.044.073.220.23991.095.32901,790.90-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-4.210.5477--13.077.27-9.42--19.44--
Data as of Jul 26 2024. Currency figures normalised to Shanghai MicroPort MedBot Group Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

3.01%Per cent of shares held by top holders
HolderShares% Held
Global X Management Co. LLCas of 03 Jul 202411.90m1.25%
The Vanguard Group, Inc.as of 04 Jul 20248.52m0.90%
HuaAn Fund Management Co., Ltd.as of 31 Dec 20232.16m0.23%
China Asset Management Co., Ltd.as of 31 Dec 20231.51m0.16%
BlackRock Fund Advisorsas of 04 Jul 20241.07m0.11%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023774.50k0.08%
BetaShares Capital Ltd.as of 31 May 2024767.11k0.08%
ALPS Advisors, Inc.as of 05 Jul 2024708.50k0.07%
E Fund Asset Management Co. Ltd.as of 31 Dec 2023636.50k0.07%
CSOP Asset Management Ltd.as of 04 Jul 2024635.85k0.07%
More ▼
Data from 31 Dec 2023 - 25 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.